Viewing Study NCT06066333


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-26 @ 1:24 AM
Study NCT ID: NCT06066333
Status: RECRUITING
Last Update Posted: 2025-09-10
First Post: 2023-09-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2026-09-27
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-09-27
Completion Date Type: ESTIMATED
First Submit Date: 2023-09-27
First Submit QC Date: None
Study First Post Date: 2023-10-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-09
Last Update Post Date: 2025-09-10
Last Update Post Date Type: ESTIMATED